FDA Targets Imaging Technologies For Regulatory Use; What s GE s End? | GenomeWeb

The US Food and Drug Administration wants digital imaging technologies to become a larger part of the drug-approval process, especially in tracking the response of cancer patients to potential therapies in clinical trials, according to a senior agency official.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.